The Efficacy and Safety of Alemtuzumab in Auotoimmune Cytopenias
Clinical trial NCT00472433 · TERMINATED
Trial details
- NCT number
- NCT00472433
- Sponsor
- Phramongkutklao College of Medicine and Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2009-05-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.